Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase

Brain Research

Volumn 1291, Issue , 2009, Pages 60-72

  Bianco, Robert A ^a   Agassandian, Khristofor ^a   Cassell, Martin D ^a,b   Spector, Arthur A ^b   Sigmund, Curt D ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Blood pressure; Neuron; Soluble epoxide hydrolase; Transgenic

Indexed keywords

EPOXIDE HYDROLASE;

ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; ASTROCYTE; BLOOD FLOW; BLOOD PRESSURE; BRAIN CORTEX; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; BRAIN; EPOXIDE HYDROLASES; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; HEART RATE; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NEURONS; TELEMETRY;

MUS MUSCULUS;

EID: 69249205387     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.07.060     Document Type: Article

References (33)

1. Aicher S.A., and Reis D.J. Gigantocellular vasodepressor area is tonically active and distinct from caudal ventrolateral vasodepressor area. Am. J. Physiol. 272 (1997) R731-R742
2. Alkayed N.J., Narayanan J., Gebremedhin D., Medhora M., Roman R.J., and Harder D.R. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 27 (1996) 971-979
3. Amruthesh S.C., Boerschel M.F., McKinney J.S., Willoughby K.A., and Ellis E.F. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes. J. Neurochem. 61 (1993) 150-159
4. Chacos N., Capdevila J., Falck J.R., Manna S., Martin-Wixtrom C., Gill S.S., Hammock B.D., and Estabrook R.W. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch. Biochem. Biophys. 223 (1983) 639-648
5. Edgerton J.R., and Reinhart P.H. Distinct contributions of small and large conductance Ca2+-activated K+ channels to rat Purkinje neuron function. J. Physiol. 548 (2003) 53-69
6. Ek M., Engblom D., Saha S., Blomqvist A., Jakobsson P.J., and Ericsson-Dahlstrand A. Inflammatory response: pathway across the blood-brain barrier. Nature 410 (2001) 430-431
7. Enayetallah A.E., French R.A., Barber M., and Grant D.F. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues. J. Histochem. Cytochem. 54 (2006) 329-335
8. Halabi C.M., Beyer A.M., de Lange W.J., Keen H.L., Baumbach G.L., Faraci F.M., and Sigmund C.D. Interference with PPARγ function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab. 7 (2008) 215-226
9. Iliff J.J., Close L.N., Selden N.R., and Alkayed N.J. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat. Exp. Physiol. 92 (2007) 653-658
10. Imig J.D., Zhao X., Capdevila J.H., Morisseau C., and Hammock B.D. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39 (2002) 690-694
11. Imig J.D., Zhao X., Zaharis C.Z., Olearczyk J.J., Pollock D.M., Newman J.W., Kim I.H., Watanabe T., and Hammock B.D. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 46 (2005) 975-981
12. Inceoglu B., Jinks S.L., Schmelzer K.R., Waite T., Kim I.H., and Hammock B.D. Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. Life Sci. 79 (2006) 2311-2319
13. Inceoglu B., Jinks S.L., Ulu A., Hegedus C.M., Georgi K., Schmelzer K.R., Wagner K., Jones P.D., Morisseau C., and Hammock B.D. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 18901-18906
14. Junier M.P., Dray F., Blair I., Capdevila J., Dishman E., Falck J.R., and Ojeda S.R. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Endocrinology 126 (1990) 1534-1540
15. Kozak W., and Fraifeld V. Non-prostaglandin eicosanoids in fever and anapyrexia. Front Biosci. 9 (2004) 3339-3355
16. Medhora M., Daniels J., Mundey K., Fisslthaler B., Busse R., Jacobs E.R., and Harder D.R. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H215-H224
17. Molnar Z., and Cheung A.F. Towards the classification of subpopulations of layer V pyramidal projection neurons. Neurosci. Res. 55 (2006) 105-115
18. Morimoto S., Cassell M.D., and Sigmund C.D. Glial- and neuronal-specific expression of the renin-angiotensin system in brain alters blood pressure, water intake, and salt preference. J. Biol. Chem. 277 (2002) 33235-33241
19. Motoki A., Merkel M.J., Packwood W.H., Cao Z., Liu L., Iliff J., Alkayed N.J., and Van Winkle D.M. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H2128-H2134
20. Munzenmaier D.H., and Harder D.R. Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1163-H1167
21. Rawal S., Morisseau C., Hammock B.D., and Shivachar A.C. Differential subcellular distribution and colocalization of the microsomal and soluble epoxide hydrolases in cultured neonatal rat brain cortical astrocytes. J. Neurosci. Res. 87 (2009) 218-227
22. Schmelzer K.R., Kubala L., Newman J.W., Kim I.H., Eiserich J.P., and Hammock B.D. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9772-9777
23. Schmelzer K.R., Inceoglu B., Kubala L., Kim I.H., Jinks S.L., Eiserich J.P., and Hammock B.D. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13646-13651
24. Sellers K.W., Sun C., ez-Freire C., Waki H., Morisseau C., Falck J.R., Hammock B.D., Paton J.F., and Raizada M.K. Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat. FASEB J. 19 (2005) 626-628
25. Snyder G.D., Yadagiri P., and Falck J.R. Effect of epoxyeicosatrienoic acids on growth hormone release from somatotrophs. Am. J. Physiol. 256 (1989) E221-E226
26. Spector A.A., and Norris A.W. Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol. 292 (2007) C996-1012
27. Terashvili M., Tseng L.F., Wu H.E., Narayanan J., Hart L.M., Falck J.R., Pratt P.F., and Harder D.R. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol. Exp. Ther. 326 (2008) 614-622
28. Yu Z., Davis B.B., Morisseau C., Hammock B.D., Olson J.L., Kroetz D.L., and Weiss R.H. Vascular localization of soluble epoxide hydrolase in the human kidney. Am. J. Physiol Renal. Physiol. 286 (2004) F720-F726
29. Zeldin D.C., Foley J., Boyle J.E., Moomaw C.R., Tomer K.B., Parker C., Steenbergen C., and Wu S. Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology 138 (1997) 1338-1346
30. Zhang C., and Harder D.R. Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocytic epoxyeicosatrienoic Acid. Stroke 33 (2002) 2957-2964
31. Zhang W., Koerner I.P., Noppens R., Grafe M., Tsai H.J., Morisseau C., Luria A., Hammock B.D., Falck J.R., and Alkayed N.J. Soluble epoxide hydrolase: a novel therapeutic target in stroke. J. Cereb. Blood Flow Metab. 27 (2007) 1931-1940
32. Zhang W., Otsuka T., Sugo N., Ardeshiri A., Alhadid Y.K., Iliff J.J., DeBarber A.E., Koop D.R., and Alkayed N.J. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39 (2008) 2073-2078
33. Zhao X., Yamamoto T., Newman J.W., Kim I.H., Watanabe T., Hammock B.D., Stewart J., Pollock J.S., Pollock D.M., and Imig J.D. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 15 (2004) 1244-1253